lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
274 rows where filing_period = "second_quarter", filing_year = 2018 and issue_code = "MED" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, income_amount, is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2138924 | HB STRATEGIES a0efc22c-815b-4b4e-965b-1eb37ba7e514 | 2T | HB STRATEGIES | 401104718 | MIDWEST ASSOCIATION FOR MEDICAL EQUIPMENT SERVICES | 2018 | second_quarter | MED | CMS reimbursements for durable medical equipment | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 1 | 2018-06-04T13:34:53.107000-04:00 | |
| 2138928 | SRI INTERNATIONAL d6090b62-b270-458a-bc0f-4aa8d878ddaf | 2T | SRI INTERNATIONAL | 90990 | SRI INTERNATIONAL | 2018 | second_quarter | MED | FY18 Omnibus Appropriations FY19 Labor-HHS-Education Appropriations | HOUSE OF REPRESENTATIVES,SENATE | 8000 | 0 | 1 | 2018-06-04T14:46:57.087000-04:00 | |
| 2139483 | LOCKRIDGE, GRINDAL, NAUEN, PLLP 88a94a5c-eb04-4502-8200-8513de58ba6f | Q2 | LOCKRIDGE, GRINDAL, NAUEN, PLLP | 23053 | HENNEPIN COUNTY MEDICAL CENTER | 2018 | second_quarter | MED | FY2019 Authorizations, Appropriations, and Budget Policy | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2018-06-27T12:19:06.690000-04:00 | ||
| 2139662 | MARSHALL BRACHMAN 4fd48fe3-a18a-4585-81b8-11418ab8fc94 | Q2 | MARSHALL BRACHMAN | 6848 | BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM | 2018 | second_quarter | MED | support funding for medical research programs | HOUSE OF REPRESENTATIVES,SENATE | 33000 | 0 | 0 | 2018-07-01T14:50:11.767000-04:00 | |
| 2139733 | OTT BIELITZKI & O'NEILL PLLC 64cb5c68-a1e1-4412-b8db-15ef1a6a84f5 | Q2 | OTT BIELITZKI & O'NEILL PLLC | 401103584 | BIOPORTO DIAGNOSTICS A/S | 2018 | second_quarter | MED | BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals. | Agriculture, Dept of (USDA),Defense, Dept of (DOD),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2018-07-02T08:04:09.520000-04:00 | |
| 2139855 | ACT FOR NIH 26455925-f533-4db6-81cc-a62db6bdcd2d | Q2 | ACT FOR NIH | 401103441 | ACT FOR NIH | 2018 | second_quarter | MED | Advocacy efforts to increase funding for NIH. | HOUSE OF REPRESENTATIVES,SENATE | 140000 | 0 | 0 | 2018-07-02T13:11:54.550000-04:00 | |
| 2140081 | MR. BRIAN KELLY e1d5e7b3-09cd-4275-91c1-67c5c64f6047 | Q2 | MR. BRIAN KELLY | 40024191 | INTELLIA THERAPEUTICS | 2018 | second_quarter | MED | Gene Editing | Defense Advanced Research Projects Agency (DARPA),Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,White House Office | 15000 | 0 | 0 | 2018-07-03T11:36:05.550000-04:00 | |
| 2140238 | NATIONAL ENVIRONMENTAL HEALTH ASSOCIATION 68e2efe5-687b-448e-b0bd-b217f58ea2a2 | Q2 | NATIONAL ENVIRONMENTAL HEALTH ASSOCIATION | 401103538 | NATIONAL ENVIRONMENTAL HEALTH ASSOCIATION | 2018 | second_quarter | MED | Increase funding for labs for Zika research | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2018-07-04T12:13:36.203000-04:00 | ||
| 2140706 | FEDERAL SOLUTIONS, LLC fe9d771d-5157-4afd-af53-a51523bc70f1 | Q2 | FEDERAL SOLUTIONS, LLC | 311371 | MISSISSIPPI STATE UNIVERSITY | 2018 | second_quarter | MED | Labor/HHS/Education Appropriation Bill: Provisions relating to disease research. | Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE | 50000 | 0 | 0 | 2018-07-06T15:04:27.700000-04:00 | |
| 2140903 | ALZHEIMER'S FOUNDATION OF AMERICA dccd3711-b745-49a9-937f-d02376445df4 | Q2 | ALZHEIMER'S FOUNDATION OF AMERICA | 323158 | ALZHEIMER'S FOUNDATION OF AMERICA | 2018 | second_quarter | MED | S. 445 - the Home Health Care Planning Improvement Act of 2017 S. 464 - Independence at Home Act of 2017 H.R. 1825, Home Health Care Planning Act | Administration on Aging,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office | 36000 | 0 | 0 | 2018-07-08T12:03:13.213000-04:00 | |
| 2140982 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER afd75a50-5f71-4808-acba-2c9381020ca4 | Q2 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 312496 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 2018 | second_quarter | MED | NIH funding HHS budget bill, PREA re-authorization, cancer moonshot, Children's Hospital Graduate Medical Education, 340B drug pricing, Children's Health Insurance Program reauthorizartion, Children's Hospital graduate medical education, Neonatal abstinence syndrome, ACE kids act | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 52635 | 0 | 0 | 2018-07-09T10:41:45.093000-04:00 | |
| 2140988 | MCDERMOTT WILL & SCHULTE LLP 1032de9f-89cd-4016-b84e-51f21894bda9 | Q2 | MCDERMOTT WILL & SCHULTE LLP | 24338 | MAYO CLINIC | 2018 | second_quarter | MED | Issues impacting academic medical centers. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2018-07-09T10:49:51.233000-04:00 | |
| 2141123 | AMERICAN SOCIETY FOR CLINICAL PATHOLOGY c6f02334-dc3a-4cfe-931f-6f80f7662b8f | Q2 | AMERICAN SOCIETY FOR CLINICAL PATHOLOGY | 3435 | AMERICAN SOCIETY FOR CLINICAL PATHOLOGY | 2018 | second_quarter | MED | Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases | Agency for Healthcare Research & Quality (AHRQ),Bureau of Labor Statistics (BLS),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Veterans Affairs, Dept of (VA),White House Office | 54250 | 0 | 0 | 2018-07-09T14:26:41.427000-04:00 | |
| 2141340 | JEFFREY J. KIMBELL & ASSOCIATES, INC. 3b7b85ca-203a-4790-a179-fcd17ac53cd1 | Q2 | JEFFREY J. KIMBELL & ASSOCIATES, INC. | 46038 | SANTHERA PHARMACEUTICALS (USA), INC. | 2018 | second_quarter | MED | Issues related to development of treatments for rare diseases. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2018-07-09T18:32:32.673000-04:00 | |
| 2141343 | JEFFREY J. KIMBELL & ASSOCIATES, INC. 06bc8a3d-14f7-4254-ae26-e3ce6b54a2fa | Q2 | JEFFREY J. KIMBELL & ASSOCIATES, INC. | 46038 | SPECTRUM PHARMACEUTICALS, INC. | 2018 | second_quarter | MED | Issues related to development of oncology treatments | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2018-07-09T18:38:37.957000-04:00 | ||
| 2141415 | MCDERMOTT+ LLC c2b23125-e7bc-4b9b-9f84-f7c618bc5a8a | Q2 | MCDERMOTT+ LLC | 401103287 | COALITION FOR 21ST CENTURY MEDICINE | 2018 | second_quarter | MED | Issues concerning regulation of laboratory-developed tests. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 80000 | 0 | 0 | 2018-07-10T09:27:12.700000-04:00 | |
| 2141669 | FRANCIS EDWARD & CRONIN, INC. ea38146c-8088-4253-b83a-1a661b646d64 | Q2 | FRANCIS EDWARD & CRONIN, INC. | 311314 | CURE ALZHEIMER'S FUND | 2018 | second_quarter | MED | Legislation related to Alzheimer's disease research. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE | 20000 | 0 | 0 | 2018-07-10T14:01:37.170000-04:00 | |
| 2141673 | FRANCIS EDWARD & CRONIN, INC. ef1bd6c8-ab92-4f99-b271-685f86bc3b0e | Q2 | FRANCIS EDWARD & CRONIN, INC. | 311314 | PATH DECISION SUPPORT SOFTWARE, LLC | 2018 | second_quarter | MED | Issues and legislation related to diabetes diagnosis and treatment. | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 0 | 0 | 2018-07-10T14:02:41.263000-04:00 | ||
| 2141712 | KD ADVOCACY AND CONSULTING, LLC 34d74480-265a-47c3-8c8d-2bdd29f3c6b5 | Q2 | KD ADVOCACY AND CONSULTING, LLC | 401103971 | REACHING MILESTONES | 2018 | second_quarter | MED | Improve access to applied behavior analysis therapy and related services for TRICARE beneficiaries with developmental disorders. | Defense, Dept of (DOD) | 0 | 0 | 2018-07-10T14:39:27.580000-04:00 | ||
| 2141721 | KD ADVOCACY AND CONSULTING, LLC 350793c2-f6bc-424f-9838-395d21aef94b | Q2 | KD ADVOCACY AND CONSULTING, LLC | 401103971 | PRIORITIES ABA | 2018 | second_quarter | MED | Improve access and efficiency of delivery of applied behavior analysis under the military TRICARE health program. | Defense, Dept of (DOD) | 0 | 0 | 2018-07-10T14:41:31.473000-04:00 | ||
| 2141779 | AMERICAN COLLEGE OF CLINICAL PHARMACY 78d3484b-36d1-4e62-8af4-f91cdfdc35f8 | Q2 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2018 | second_quarter | MED | Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 144981 | 0 | 0 | 2018-07-10T15:03:15.193000-04:00 | |
| 2141946 | THE CJR GROUP, INC. 244628d9-5393-402d-8680-7d1a125f9ff0 | Q2 | THE CJR GROUP, INC. | 288293 | UNIVERSITY HOSPITALS HEALTH SYSTEM | 2018 | second_quarter | MED | Issues impacting hospitals | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2018-07-10T17:36:43.537000-04:00 | |
| 2141975 | RAY C CULVER III 964f1ee2-de67-492e-8547-1c374ee1770a | Q2 | RAY C CULVER III | 11468 | ARKANSAS CHILDREN'S HOSPITAL | 2018 | second_quarter | MED | Funding for the USDA Agricultural Research Service human nutrition research centers in the FY18 Consolidated Appropriations Act, PL 115-141 (Division A), and in the FY19 House and Senate Agricultural Appropriations bills currently being considered. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2018-07-10T19:55:26.207000-04:00 | |
| 2142053 | BROWN RUDNICK LLP 8f023c41-4282-4ba5-83ea-583b4787509c | 2A | BROWN RUDNICK LLP | 287895 | HOOPER LUNDY & BOOKMAN P C (OBO ROCHE DIAGNOSTICS) | 2018 | second_quarter | MED | Diagnostic Accuracy & Innovation Act (DAIA)Discussion Draft | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2018-07-11T10:11:42.780000-04:00 | |
| 2142195 | AMERICAN GASTROENTEROLOGICAL ASSOCIATION 05787df8-83c6-4d94-ad59-91d5642c1234 | Q2 | AMERICAN GASTROENTEROLOGICAL ASSOCIATION | 59650 | AMERICAN GASTROENTEROLOGICAL ASSOCIATION | 2018 | second_quarter | MED | Lobbied in support of increased funding for the NIH, NIDDK, NCI and federal research funding for DoD and the VA. | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 80000 | 0 | 0 | 2018-07-11T11:23:21.320000-04:00 | |
| 2142567 | THE O TEAM LLC 3800e79a-edd7-4eca-b82c-f71b597907ea | Q2 | THE O TEAM LLC | 400783359 | THE SUZANNE WRIGHT FOUNDATION | 2018 | second_quarter | MED | Pancreatic cancer awareness. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2018-07-11T15:38:45.680000-04:00 | |
| 2142823 | O'NEILL AND ASSOCIATES 0afc19a8-0eb5-4a1e-a0c3-d10fac49bc2c | Q2 | O'NEILL AND ASSOCIATES | 73134 | POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN) | 2018 | second_quarter | MED | Medicare advantage and health care reform | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2018-07-12T10:24:48.843000-04:00 | |
| 2142856 | SQUIRE PATTON BOGGS 1d88db57-9f54-467c-9595-a92a23369cf0 | Q2 | SQUIRE PATTON BOGGS | 30906 | IMPACT JOURNALS, LLC | 2018 | second_quarter | MED | National Library of Medicine publication and archive matters. | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 50000 | 0 | 0 | 2018-07-12T10:53:15.050000-04:00 | |
| 2142858 | SQUIRE PATTON BOGGS de8550b8-efec-48d5-ab1f-724625c0f21a | Q2 | SQUIRE PATTON BOGGS | 30906 | MOLNLYCKE HEALTH CARE US, LLC | 2018 | second_quarter | MED | Working with congressional leaders to improve pressure ulcer reimbursement and awareness and other hospital acquired conditions. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2018-07-12T10:57:17.143000-04:00 | |
| 2142901 | SQUIRE PATTON BOGGS 581cfe7f-efdc-49da-9e37-018642d5884b | Q2 | SQUIRE PATTON BOGGS | 30906 | UNIVERSITY OF GEORGIA | 2018 | second_quarter | MED | Traumatic brain injury research, funding, and outreach opportunities. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2018-07-12T11:22:41.600000-04:00 | |
| 2142942 | FAEGRE DRINKER BIDDLE & REATH LLP 70a0b551-d39a-4449-9a9a-dcaacca97440 | Q2 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE | 2018 | second_quarter | MED | Public Health Programs for Infectious and Tropical Disease and Anti-Microbial Resistance; NIH Research; Draft House Pandemic and All Hazards Preparedness Reauthorization; CDC Director appointment; S. 2852 Pandemic and All Hazards Preparedness and Advancing Innovation Act. | Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2018-07-12T11:40:20.070000-04:00 | |
| 2142970 | FAEGRE DRINKER BIDDLE & REATH LLP 53ac7b9a-6ae4-431f-b618-76499a6c9e3c | Q2 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA | 2018 | second_quarter | MED | Neglected Tropical Disease Research and Development; Draft House Pandemic and All Hazards Preparedness Act Re-authorization; S. 2852, Pandemic and All Hazards Preparedness and Advancing Innovation Act. | SENATE | 10000 | 0 | 0 | 2018-07-12T11:56:31.697000-04:00 | |
| 2142998 | FAEGRE DRINKER BIDDLE & REATH LLP 66b6a418-f8f4-4090-b604-5f6fff23a466 | Q2 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH | 2018 | second_quarter | MED | Draft House Pandemic All Hazards Preparedness Act Reauthorization; S.2852, Pandemic and All Hazards Preparedness and Advancing Innovation Act | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2018-07-12T12:19:52.357000-04:00 | |
| 2143017 | MARSHFIELD CLINIC HEALTH SYSTEM 3e9a7128-71ff-43c4-bd99-bcc29890b8da | Q2 | MARSHFIELD CLINIC HEALTH SYSTEM | 57830 | MARSHFIELD CLINIC HEALTH SYSTEM | 2018 | second_quarter | MED | MED (Medical Disease Research/ Clinical Labs) Protecting Access to Medicare Act of 2014 (PAMA) PAMA includes reforms to the Clinical Lab Fee Schedule (CLFS). This rule for PAMA requires reporting of Clinical lab prices and volumes. MCHS requested a delay in the reporting, and changes to expand the definition of applicable lab to represent the true market of all laboratories; requested greater transparency of calculations; more time to allow for gathering data and implementation. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 100000 | 0 | 0 | 2018-07-12T12:28:04.530000-04:00 | |
| 2143070 | THE PAUL LAXALT GROUP b83e13ee-c0bf-4d04-9431-dab0b8afff05 | Q2 | THE PAUL LAXALT GROUP | 22325 | THE ROGOSIN INSTITUTE | 2018 | second_quarter | MED | Monitor issues concerning improvements in medical research and treatment of kidney disease. Dialysis PATIENTS Demonstration Act of 2017 - HR 4143 and S 2065 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 - HR 2644 and S 1980 | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2018-07-12T13:40:43.570000-04:00 | |
| 2143155 | SQUIRE PATTON BOGGS 10a80693-7f6c-43e8-b5b5-f59d825d3583 | Q2 | SQUIRE PATTON BOGGS | 30906 | ALLIANCE FOR BIOSECURITY | 2018 | second_quarter | MED | Preparedness and response as it relates to Biosecurity. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2018-07-12T15:09:36.260000-04:00 | |
| 2143212 | AMERICAN OSTEOPATHIC ASSOCIATION df739a65-4879-4482-b73c-8363c6475432 | Q2 | AMERICAN OSTEOPATHIC ASSOCIATION | 3014 | AMERICAN OSTEOPATHIC ASSOCIATION | 2018 | second_quarter | MED | NIH; FDA | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE,White House Office | 286075 | 0 | 0 | 2018-07-12T15:43:04.793000-04:00 | |
| 2143586 | AMERICAN ACADEMY OF PHYSICAL MEDICINE AND REHABILITATION 7347f9af-a92f-4037-8a85-b6a1bb15b76f | Q2 | AMERICAN ACADEMY OF PHYSICAL MEDICINE AND REHABILITATION | 400864533 | AMERICAN ACADEMY OF PHYSICAL MEDICINE AND REHABILITATION | 2018 | second_quarter | MED | Coalition meeting and sign on letters to NIH regarding rehabilitation research funding and the proposal to move NIDILRR to NIH. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE | 10000 | 0 | 0 | 2018-07-13T10:55:59.487000-04:00 | |
| 2143669 | THE FRIEDLANDER GROUP d4f11a17-84a9-424d-894e-8425fa54acf9 | Q2 | THE FRIEDLANDER GROUP | 400535604 | OHEL CHILDRENS HOME AND FAMILY SERVICES | 2018 | second_quarter | MED | Block Grants | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2018-07-13T11:43:35.227000-04:00 | ||
| 2143826 | AMERICAN PHYSICAL THERAPY ASSOCIATION a31abbfe-b44d-4acd-b24c-24331777bb8a | Q2 | AMERICAN PHYSICAL THERAPY ASSOCIATION | 3093 | AMERICAN PHYSICAL THERAPY ASSOCIATION | 2018 | second_quarter | MED | NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding AHRQ Quality measure development panel for hip fracture patients and fall risk in PAC Comments on Behavioral Counseling to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults with Known Risk Factors PT role in childhood obesity Relocate TBI State Grant Program to ACL SAFE PLAY Act | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Veterans Affairs, Dept of (VA),White House Office | 292000 | 0 | 0 | 2018-07-13T13:27:14.707000-04:00 | |
| 2143865 | POYNER SPRUILL LLP 627f9622-371b-4f3d-9687-1218c7453f1f | Q2 | POYNER SPRUILL LLP | 400563685 | AMERICAN COLLEGE OF SPORTS MEDICINE, INC. | 2018 | second_quarter | MED | vital role of physical activity and sports, fitness (including the President's Council on Physical Fitness, Nutrition and Sports), worksite wellness activities, disease prevention through healthy lifestyles, promotion of good health and diet, funding for Labor, HHS and Education Appropriation Bills, concussion legislation, good nutrition and infrastructure initiatives for pedestrians and cyclists and other health-related matters. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of the Vice President of the United States,SENATE | 9200 | 0 | 0 | 2018-07-13T14:10:39.353000-04:00 | |
| 2143900 | MARIJUANA POLICY PROJECT 4a96f022-fb66-4bbd-85b1-60afbc6b2354 | Q2 | MARIJUANA POLICY PROJECT | 74330 | MARIJUANA POLICY PROJECT | 2018 | second_quarter | MED | Advocated easing restrictions on researching marijuana (no specific bill at this point) | HOUSE OF REPRESENTATIVES,SENATE | 75000 | 0 | 0 | 2018-07-13T14:33:58.263000-04:00 | |
| 2144925 | WAKE FOREST UNIVERSITY HEALTH SCIENCES f179ab94-0a76-4fa3-a21b-198d72269bef | Q2 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 6781 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 2018 | second_quarter | MED | VA Research funding and access issues; | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 150000 | 0 | 0 | 2018-07-16T11:42:23.353000-04:00 | |
| 2144971 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 77849fb2-f2fd-448f-9155-0711f947ed6c | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | TUBEROUS SCLEROSIS ALLIANCE | 2018 | second_quarter | MED | HR6157/S3159, FY19 Defense Appropriations Act, Tuberous Sclerosis Medical Research program No HR bill number, S3158,FY19 Labor HHS Education Appropriations Act, NIH and CDC, Tuberous Sclerosis, research at the National Institutes of Health and the Centers for Disease Control and Prevention. | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2018-07-16T12:00:45.207000-04:00 | |
| 2145014 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. c8ec74aa-b0f8-43eb-8895-e46b6c3e4d95 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | PANCREATIC CANCER ACTION NETWORK (PANCAN) | 2018 | second_quarter | MED | HR 6157/S 3159, FY19, Defense Appropriations Act, Peer-Reviewed Cancer Research Program, NIH No HR bill no/S 3158, FY19, Labor HHS Education Appropriations Act, NIH funding | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 40000 | 0 | 0 | 2018-07-16T12:15:16.240000-04:00 | |
| 2145095 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. e6509e90-7bde-49d9-936e-f2738c108f37 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION | 2018 | second_quarter | MED | Research opportunities at the Department of Defense and the Centers for Disease Control. HR 6157/S 3159, FY19 Defense Appropriations Act, defense medical research No HR bill no/S 3158, FY19 Labor HHS Education Appropriations Act, NIH funding | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 10000 | 0 | 0 | 2018-07-16T12:45:03.057000-04:00 | |
| 2145213 | HACKENSACK MERIDIAN HEALTH c8a5ae5c-8d3e-4b4c-9b4e-f5ee863b0bd7 | Q2 | HACKENSACK MERIDIAN HEALTH | 401104109 | HACKENSACK MERIDIAN HEALTH | 2018 | second_quarter | MED | National Institutes of Health funding Behavioral health Substance abuse, opioids, and patient data CAR-T (chimeric antigen therapy) support | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2018-07-16T13:39:11.077000-04:00 | |
| 2145415 | AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES 9d7f5d0e-6243-46a2-acf2-27a6fa11a429 | Q2 | AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES | 1524 | AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOO | 2018 | second_quarter | MED | Letter to Congress supporting the Food and Drug Administration's process related to a pending guidance entitled,Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2018-07-16T14:44:41.947000-04:00 | ||
| 2145483 | AMERICA'S BLOOD CENTERS b6277fa2-e1e2-4ca8-a5c5-5097033c55dd | Q2 | AMERICA'S BLOOD CENTERS | 3834 | AMERICA'S BLOOD CENTERS | 2018 | second_quarter | MED | Value of Blood/Reimbursement Blood center testing for Zika Bacterial risk strategies for platelets | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2018-07-16T15:18:16.793000-04:00 | |
| 2145530 | AMERICAN ORGANIZATION FOR NURSING LEADERSHIP (FORMERLY AMERICAN ORGANIZATION OF NURSE EXECUTIVES 65f0b9d9-1ad9-498f-bbd4-67ffb729219f | Q2 | AMERICAN ORGANIZATION FOR NURSING LEADERSHIP (FORMERLY AMERICAN ORGANIZATION OF NURSE EXECUTIVES | 2992 | AMERICAN ORGANIZATION FOR NURSING LEADERSHIP FORMERLY AMERICAN ORGANIZATION FOR | 2018 | second_quarter | MED | Lobbying for the National Institute of Nursing Research | Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Indian Health Service,Labor, Dept of (DOL),SENATE,Veterans Affairs, Dept of (VA) | 40000 | 0 | 0 | 2018-07-16T15:35:39.403000-04:00 | |
| 2145792 | LNE GROUP aba6a0da-1178-4b4e-894e-b1e8692655f9 | Q2 | LNE GROUP | 308811 | HOSPICE OF THE WESTERN RESERVE | 2018 | second_quarter | MED | Lobbied on issues related to medical/disease research. | HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 20000 | 0 | 0 | 2018-07-16T17:10:01.243000-04:00 | |
| 2146042 | BROYDRICK & ASSOCIATES 02eef885-bfab-4bc9-a657-47536be92449 | Q2 | BROYDRICK & ASSOCIATES | 7268 | EXACT SCIENCES | 2018 | second_quarter | MED | Legislation on cancer screening test process. | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2018-07-16T21:59:41.957000-04:00 | |
| 2146103 | IMPACT HEALTH POLICY PARTNERS c9cb0ade-9a5c-4464-bc78-2264ef192784 | Q2 | IMPACT HEALTH POLICY PARTNERS | 401104696 | ABBOTT LABORATORIES | 2018 | second_quarter | MED | Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2018-07-16T23:50:24.877000-04:00 | |
| 2146108 | IMPACT HEALTH POLICY PARTNERS b9c3b8cc-9e6d-478c-a447-7b83560edb40 | Q2 | IMPACT HEALTH POLICY PARTNERS | 401104696 | HACKENSACK MERIDIAN HEALTH | 2018 | second_quarter | MED | Issues related to research funding, NIH and other matters. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2018-07-17T00:01:26.113000-04:00 | |
| 2146113 | IMPACT HEALTH POLICY PARTNERS 25ad381b-326d-43ec-a22c-9543c443e36b | Q2 | IMPACT HEALTH POLICY PARTNERS | 401104696 | CHILDREN'S HOSPITAL COLORADO | 2018 | second_quarter | MED | Issues related to pediatric research and childrens hospital graduate medical education. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2018-07-17T00:10:29.160000-04:00 | |
| 2146131 | THE PETRIZZO GROUP, INC. b1abde04-7fe4-4f00-b7ca-cf18e869118f | Q2 | THE PETRIZZO GROUP, INC. | 305932 | ALLEN INSTITUTE | 2018 | second_quarter | MED | Advocated for funding of the BRAIN Initiative, Alzheimer's and full funding for NIH. Advocated for the development of open data hosting, and integrated, scalable data analysis hubs for the BRAIN Initiative at NIH. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2018-07-17T00:37:41.147000-04:00 | |
| 2146136 | THE PETRIZZO GROUP, INC. c45ad267-bb2f-40f4-93f8-221bec71fa70 | Q2 | THE PETRIZZO GROUP, INC. | 305932 | OMEROS CORPORATION | 2018 | second_quarter | MED | Advocated for Medicare Part B packaged payment reform. | HOUSE OF REPRESENTATIVES,SENATE | 75000 | 0 | 0 | 2018-07-17T00:39:42.303000-04:00 | |
| 2146141 | THE PETRIZZO GROUP, INC. b5502a40-7940-4bf2-ba84-c2e70f48d2da | Q2 | THE PETRIZZO GROUP, INC. | 305932 | UNITED BIOMEDICAL, INC. | 2018 | second_quarter | MED | Advocated for federal funding and development of robust vaccine research for Alzheimer's, Parkinson's and other neurological diseases. | HOUSE OF REPRESENTATIVES,Natl Institute of Mental Health (NIMH),Natl Institutes of Health (NIH),SENATE | 50000 | 0 | 0 | 2018-07-17T00:51:45.807000-04:00 | |
| 2146321 | FAEGRE DRINKER BIDDLE & REATH LLP 2e5a08e6-2450-49b5-b798-8ff42ce96b32 | Q2 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | PREECLAMPSIA FOUNDATION | 2018 | second_quarter | MED | Preeclampsia Research Issues. | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 10000 | 0 | 0 | 2018-07-17T09:49:49.497000-04:00 | |
| 2146701 | INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH d2312ef9-799b-427d-b5ee-b7eb3e0104ea | Q2 | INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH | 401104821 | INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH | 2018 | second_quarter | MED | Opposition to Right to Try Act S. 204 & H.R. 5247 | HOUSE OF REPRESENTATIVES,SENATE | 21875 | 0 | 0 | 2018-07-17T11:25:16.680000-04:00 | |
| 2146800 | ALPINE GROUP PARTNERS, LLC. 0ae36723-8e82-479c-ad6c-c375b6bc8bb5 | Q2 | ALPINE GROUP PARTNERS, LLC. | 1171 | ROBOKIND | 2018 | second_quarter | MED | Issues relating to autism education and research | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2018-07-17T11:41:16.293000-04:00 | |
| 2146826 | CATHOLIC HEALTH ASSOCIATION OF THE UNITED STATES 691bece2-c3b9-4a50-99d7-2af090c6d296 | Q2 | CATHOLIC HEALTH ASSOCIATION OF THE UNITED STATES | 8497 | CATHOLIC HEALTH ASSOCIATION OF THE UNITED STATES | 2018 | second_quarter | MED | Supported the creation of additional ICD-10-CM medical diagnosis codes to account for human trafficking victims in clinical settings. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,President of the U.S.,SENATE | 200000 | 0 | 0 | 2018-07-17T11:50:35.153000-04:00 | |
| 2146853 | SQUIRE PATTON BOGGS 1d96e7b0-b3d2-48f7-9245-23eed2d71d6b | Q2 | SQUIRE PATTON BOGGS | 30906 | THOMAS JEFFERSON UNIVERSITY | 2018 | second_quarter | MED | Advancing health system legislative and regulatory issues including: the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2018-07-17T11:55:43.887000-04:00 | |
| 2146903 | UNIVERSITY OF MIAMI 7e3825e0-9855-4936-b754-7179846b3127 | Q2 | UNIVERSITY OF MIAMI | 39462 | UNIVERSITY OF MIAMI | 2018 | second_quarter | MED | DOD - Defense Appropriations | Defense, Dept of (DOD) | 77367 | 0 | 0 | 2018-07-17T12:13:13.280000-04:00 | |
| 2146923 | P STREET PROJECT, INC. 01100252-c987-4108-9416-db3bc32affb0 | Q2 | P STREET PROJECT, INC. | 400637928 | P STREET PROJECT, INC. | 2018 | second_quarter | MED | Public health insurance option and Medicare for All (S. 1804); advocating against repeal of ACA | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2018-07-17T12:17:22.517000-04:00 | |
| 2147150 | WILLIAMS AND JENSEN, PLLC 8aee46fa-8edd-4c83-a341-2d463f1580cf | Q2 | WILLIAMS AND JENSEN, PLLC | 41454 | GLOBAL DOWN SYNDROME FOUNDATION | 2018 | second_quarter | MED | Support for down syndrome research funding. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 30000 | 0 | 0 | 2018-07-17T13:21:16.727000-04:00 | |
| 2147151 | LNE GROUP 356d05fb-be00-410a-af30-2fb1b2a27f86 | Q2 | LNE GROUP | 308811 | PARKER HANNIFIN | 2018 | second_quarter | MED | Lobbied for issues related to medical research. | HOUSE OF REPRESENTATIVES,SENATE,U.S. Coast Guard (USCG) | 80000 | 0 | 0 | 2018-07-17T13:21:18.133000-04:00 | |
| 2147370 | OREGON HEALTH & SCIENCE UNIVERSITY b25b329b-5289-4d82-b83c-4ec925079963 | Q2 | OREGON HEALTH & SCIENCE UNIVERSITY | 30291 | OREGON HEALTH & SCIENCE UNIVERSITY | 2018 | second_quarter | MED | Impact of Budget Control Act of 2011s Sequestration on medical records; use of animals in biomedical research; moving medical research from bench to beside more quickly including greater sharing of research data, reducing administrative burden on medical researchers, streamline of clinical trials, increased flexibility in the FDAs approval process for drugs and devices tried with additional review in post-market: 21st Century Cures Act (H.R> 34); FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/S. 2956); importance of research using fetal tissue; importance of Small Business Innovation Research and Small Technology Transfer Research Program; FDA regulation of laboratory developed test. | HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2018-07-17T13:56:06.293000-04:00 | |
| 2147440 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. b8d8c1cf-d276-41bf-bde9-610e5bf2c257 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ENDOCRINE SOCIETY | 2018 | second_quarter | MED | Research in Endocrinology | Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2018-07-17T14:06:34.123000-04:00 | |
| 2147474 | SIDLEY AUSTIN LLP 3558a1f7-6af0-4087-9b86-bc095a734b16 | Q2 | SIDLEY AUSTIN LLP | 35230 | CORD BLOOD ASSOCIATION | 2018 | second_quarter | MED | Legislative and Federal agency activities related to the Stem Cell Therapeutic and Research Reauthorization Act of 2015 | Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA) | 20000 | 0 | 0 | 2018-07-17T14:11:47.340000-04:00 | |
| 2147771 | WILLIAM HILLEARY e2857938-fa5d-4b48-89d3-7e1d1341404a | Q2 | WILLIAM HILLEARY | 401103801 | WILLIAMS & JENSEN ON BEHALF OF GLOBAL DOWN SYNDROME FOUNDATION | 2018 | second_quarter | MED | Support for down syndrome research funding. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2018-07-17T15:12:09.130000-04:00 | ||
| 2147797 | INTUITIVE SURGICAL, INC. 28cd5522-1bc0-4e61-b56a-a5d01644d782 | Q2 | INTUITIVE SURGICAL, INC. | 400670004 | INTUITIVE SURGICAL, INC. | 2018 | second_quarter | MED | comparative effectiveness research in healthcare | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2018-07-17T15:16:20.423000-04:00 | |
| 2148027 | HANCE SCARBOROUGH 6a2dcf83-b335-439e-a9c7-477a418cec59 | Q2 | HANCE SCARBOROUGH | 17443 | TITAN PHARMACEUTICALS, INC. | 2018 | second_quarter | MED | Medicare/Medicaid drug coverage,opioid addiction policy, S.2456 The CARA 2.0 Act of 2018. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2018-07-17T15:50:07.813000-04:00 | ||
| 2148192 | CARMEN GROUP INCORPORATED 3410753d-cc8a-4763-a69c-3285f38e0040 | Q2 | CARMEN GROUP INCORPORATED | 8316 | BIOREFERENCE LABORATORIES, INC. | 2018 | second_quarter | MED | Delaying implementation of the Clinical Laboratory Fees Schedule; Support Local Coverage Determination process legislation; Concern about FDA regulation of clinical labs; Authorization of the 4K score test for prostrate cancer; MAC review of lab testing; National Coverage decision on genetic testing. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 45000 | 0 | 0 | 2018-07-17T16:16:28.847000-04:00 | |
| 2148599 | EFB ADVOCACY, LLC 6f9f003d-c209-4cce-81ab-f68a4ee7e17f | Q2 | EFB ADVOCACY, LLC | 401104430 | UNITED FOR MEDICAL RESEARCH | 2018 | second_quarter | MED | Funding issues related to National Institutes of Health | HOUSE OF REPRESENTATIVES,SENATE | 45000 | 0 | 0 | 2018-07-17T20:56:09.693000-04:00 | |
| 2148740 | SPINA BIFIDA ASSOCIATION OF AMERICA 622c9d4f-daba-49f5-9398-c540d07b8bb5 | Q2 | SPINA BIFIDA ASSOCIATION OF AMERICA | 46665 | SPINA BIFIDA ASSOCIATION OF AMERICA | 2018 | second_quarter | MED | Activities to support the Spina Bifida community and research relating to all people affected by Spina Bifida | Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 82636 | 0 | 0 | 2018-07-18T07:27:58.240000-04:00 | |
| 2148777 | AMERICAN CLINICAL LABORATORY ASSN 96702f9e-825d-4528-8b19-f01a2305e0a3 | Q2 | AMERICAN CLINICAL LABORATORY ASSN | 1923 | AMERICAN CLINICAL LABORATORY ASSN | 2018 | second_quarter | MED | regulation and oversight of clinical laboratories, including laboratory developed test services, the Diagnostic Accuracy and Innovation Act; reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, TRICARE coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); reauthorization of FDA user fees; narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; National Diabetes Prevention Program; commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (S 2852/HR 6378); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2018 and FY2019; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2018 and FY2019 (S3158); H.R.1625 Vehicle for Consolidated Appropriations Act 2018; Medicare reimbursement of clinical laboratory services | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office | 173334 | 0 | 0 | 2018-07-18T08:17:28.200000-04:00 | |
| 2149128 | INDIANA CHAMBER OF COMMERCE, INC. 9524b66d-9cb5-4dd8-9a91-29fc94153934 | Q2 | INDIANA CHAMBER OF COMMERCE, INC. | 19263 | INDIANA CHAMBER OF COMMERCE INC | 2018 | second_quarter | MED | FDA facility inspection and export certificate processes for medical device manufacturers. | HOUSE OF REPRESENTATIVES,President of the U.S.,SENATE | 20000 | 0 | 0 | 2018-07-18T10:05:13.457000-04:00 | |
| 2149202 | BALLARD PARTNERS e5f9c292-fe20-4285-bd93-28a222563b6b | Q2 | BALLARD PARTNERS | 401104288 | THE SUZANNE WRIGHT FOUNDATION | 2018 | second_quarter | MED | Establishing a Funding Source for Medical Research | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 80000 | 0 | 0 | 2018-07-18T10:20:12.097000-04:00 | |
| 2149227 | BAKER BOTTS, L.L.P. 6c50f55e-1e98-4b16-bcf1-7ba54bdb5f22 | Q2 | BAKER BOTTS, L.L.P. | 5118 | SOUTHERN METHODIST UNIVERSITY | 2018 | second_quarter | MED | Funding of research into detecting traumatic brain injury. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2018-07-18T10:25:25.443000-04:00 | |
| 2149352 | BALLARD PARTNERS f01d355d-19f5-4125-b7d8-c47accf8e734 | Q2 | BALLARD PARTNERS | 401104288 | LABORATORY CORPORATIONS OF AMERICA HOLDINGS | 2018 | second_quarter | MED | Clinical Lab Rates | White House Office | 80000 | 0 | 0 | 2018-07-18T10:41:24.023000-04:00 | |
| 2149376 | WASHINGTON STATE UNIVERSITY 4dcda408-a83b-4e8d-9fad-f19ff6ec4866 | Q2 | WASHINGTON STATE UNIVERSITY | 40657 | WASHINGTON STATE UNIVERSITY | 2018 | second_quarter | MED | Medical Education, graduate medical education, teaching health centers, antimicrobial resistance, facilities and administrative costs, opioid research | Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Education, Dept of,Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Natl Science Foundation (NSF),Office of Management & Budget (OMB),Office of Natl Drug Control Policy (NDCP),SENATE,White House Office | 49765 | 0 | 0 | 2018-07-18T10:44:32.523000-04:00 | |
| 2149486 | SPLITOAK STRATEGIES LLC b6f0318f-7a57-4f87-a1c5-92ea2d627199 | Q2 | SPLITOAK STRATEGIES LLC | 401104582 | CARIS SCIENCE INC | 2018 | second_quarter | MED | FDA oversight of Next Generation Sequencing technology for advanced cancers. Medicare coverage of Next Generation Sequencing technology for advanced cancers. Finalize PAMA reform of Medicare clinical lab payments. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2018-07-18T10:58:20.507000-04:00 | |
| 2149490 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 1a648fc7-cda8-433b-b6b5-60623cfd6e2c | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ASSOCIATION FOR MOLECULAR PATHOLOGY | 2018 | second_quarter | MED | Regulation of laboratory diagnostics No bill number, Diagnostic Accuracy and Innovation Act HR 5062, Advancing Access to Precision Medicine Act | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2018-07-18T10:58:21.633000-04:00 | |
| 2149682 | WILLIAMS AND JENSEN, PLLC 5a90f97a-fe8d-4a0e-9aea-efba02a535da | Q2 | WILLIAMS AND JENSEN, PLLC | 41454 | MT PHARMA AMERICA, INC. | 2018 | second_quarter | MED | Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2018-07-18T11:28:02.217000-04:00 | |
| 2149741 | FEDERAL SCIENCE PARTNERS LLC b91fbd0e-3d06-4aa0-93de-2fd44adeace0 | Q2 | FEDERAL SCIENCE PARTNERS LLC | 401103311 | AMERICAN SOCIETY OF ANESTHESIOLOGISTS | 2018 | second_quarter | MED | NIH research support for opioids and other pain-related drugs | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 15000 | 0 | 0 | 2018-07-18T11:37:26.920000-04:00 | |
| 2149829 | TCH GROUP, LLC 5b1ae08f-24f2-4c22-bcc5-1638be220b33 | Q2 | TCH GROUP, LLC | 51478 | INTERNATIONAL AIDS VACCINE INITIATIVE | 2018 | second_quarter | MED | FY 19 House and Senate State Foreign Operations Subcommittee Appropriations bills (HR 6385 and S 3108). Specifically, continued Federal funding under USAID for AIDS vaccine research and development | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2018-07-18T11:57:21.390000-04:00 | |
| 2150077 | MWW GROUP c6fc5756-8d06-4d0c-9890-f7abf6b83851 | Q2 | MWW GROUP | 26318 | THOMAS JEFFERSON UNIVERSITY AND HEALTH SYSTEM | 2018 | second_quarter | MED | NCI designated cancer centers program; Computational Biology; Funding for NIH Specialized Programs of Research Excellence (SPORE) grants; Health disparities research; Regional Clinical Trial networks; Telestroke/telehealth/telemedicine programs; Global programs; Campus visits on research | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2018-07-18T12:44:22.927000-04:00 | |
| 2150194 | BARNES & THORNBURG, LLP 10a54ce8-9572-4306-bf8b-8fc9db589529 | Q2 | BARNES & THORNBURG, LLP | 5404 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2018 | second_quarter | MED | Legislative and regulatory issues of interest to research-based pharmaceutical industry. | HOUSE OF REPRESENTATIVES,Office of the Vice President of the United States,SENATE | 80000 | 0 | 0 | 2018-07-18T13:29:47.963000-04:00 | |
| 2150257 | INDIANA UNIVERSITY 9ad31b52-b17c-4e9e-a1dd-f5b9ff8c8428 | Q2 | INDIANA UNIVERSITY | 296236 | INDIANA UNIVERSITY | 2018 | second_quarter | MED | The National Institutes of Health (NIH) Clinical and Translational Science Awards (CTSA) program and the IU Clinical and Translational Science Institute (CTSI). | HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2018-07-18T13:42:19.980000-04:00 | |
| 2150272 | FAEGRE DRINKER BIDDLE & REATH LLP 16bd3058-a43f-473e-966f-0e75c85b630d | Q2 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | MARCH OF DIMES FOUNDATION | 2018 | second_quarter | MED | (HR. 6085, S. 3029) PREEMIE Re-authorization Act. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2018-07-18T13:48:28.403000-04:00 | |
| 2150390 | STANFORD UNIVERSITY c3f60ae8-3e4c-442b-bcb2-f84ee66b8d7b | Q2 | STANFORD UNIVERSITY | 36492 | STANFORD UNIVERSITY | 2018 | second_quarter | MED | Affordable Care Act Reform Health Professions Programs Graduate Medical Education Funding Pediatric GME Programs Precision Medicine Initiative | Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE,Treasury, Dept of | 90000 | 0 | 0 | 2018-07-18T14:15:45.327000-04:00 | |
| 2150603 | UNIVERSITY OF ROCHESTER 7856394d-4402-444c-b6e9-45b80303423f | Q2 | UNIVERSITY OF ROCHESTER | 301937 | UNIVERSITY OF ROCHESTER | 2018 | second_quarter | MED | P.L. 114-255, 21st Century Cures Act | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2018-07-18T14:56:30.740000-04:00 | |
| 2150780 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 33ea7ae9-2004-4082-977c-68f9d3e70a07 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | 23ANDME, INC. | 2018 | second_quarter | MED | Direct to Consumer Genetic Testing | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2018-07-18T15:21:36.650000-04:00 | |
| 2151056 | BRACEWELL LLP 8af7a71f-4c6b-469b-886b-59171509a37e | Q2 | BRACEWELL LLP | 6837 | NATIONAL BRAIN TUMOR SOCIETY | 2018 | second_quarter | MED | work related to the advancement of the Cancer Drug Coverage Parity Act and STAR Act | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2018-07-18T15:55:35.217000-04:00 | |
| 2151377 | BRACEWELL LLP e51d4afb-76d0-40ce-9dd6-70f777610c32 | Q2 | BRACEWELL LLP | 6837 | AIR LIQUIDE USA LLC | 2018 | second_quarter | MED | Work related to medical gases | Bureau of Land Management (BLM),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),Internal Revenue Service (IRS),SENATE,Treasury, Dept of | 84000 | 0 | 0 | 2018-07-18T16:29:56.093000-04:00 | |
| 2151465 | K&L GATES, LLP e0581bce-7380-4f6c-b502-1dcd702ee2ea | 2T | K&L GATES, LLP | 32098 | VGM GROUP, INC. D/B/A VGM & ASSOCIATES | 2018 | second_quarter | MED | S. 2175 - BREATH ACT of 2017 - all provisions. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 1 | 2018-07-18T16:40:40.157000-04:00 | |
| 2151493 | THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) b5eb2663-178f-4b94-bd98-5288365a71e4 | Q2 | THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) | 2970 | THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) | 2018 | second_quarter | MED | No bill: Support robust funding for medical research within National Institutes of Health (NIH), Centers for Disease Control (CDC), and National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR). Oppose administration proposal to move NIDILRR from the Administration for Community Living (ACL) to NIH. | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 270000 | 0 | 0 | 2018-07-18T16:43:51.580000-04:00 | |
| 2151894 | MOLNLYCKE HEALTH CARE US, LLC bae246ab-ae9f-4fe0-a612-e3fcbfe63300 | 2A | MOLNLYCKE HEALTH CARE US, LLC | 401104898 | MOLNLYCKE HEALTH CARE US, LLC | 2018 | second_quarter | MED | Pursuance of approval from relevant agencies of a medical pilot program and gathering support from Congressional leaders. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2018-07-18T17:39:13.807000-04:00 | |
| 2152005 | HOOPER, LUNDY & BOOKMAN, P.C. 6ab9d39a-e1e2-460f-9ccc-8161afac0705 | Q2 | HOOPER, LUNDY & BOOKMAN, P.C. | 401020884 | ROCHE DIAGNOSTICS CORPORATION | 2018 | second_quarter | MED | Diagnostic Accuracy & Innovation Act (DAIA) Duiscussion Draft. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2018-07-18T17:55:01.807000-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);